Stake Completed
BDT & MSD Partners stake in DBG Health
A$1.6bn consideration
Announced Aug 2025 (approx.)
Advisers
- Target
- DBG Health
- Acquirer
- BDT & MSD Partners
- Seller
- DBG Health
- Structure
- Private sale
- Completed
- 18 Aug 2025
- Equity value
- A$7bn
- Sector
- Biotech and pharmaceuticals
In the league tables
Similar deals
- BGH Capital acquisition of Aspen Pharmacare Asia Pacific business Jun 2026 · A$2.4bn · Biotech and pharmaceuticals
- Telix Pharmaceuticals and ITM Isotope Technologies Munich SE merger Sep 2026 · A$3.3bn · Biotech and pharmaceuticals
- Avista Healthcare Partners acquisition of Mayne Pharma Group Feb 2025 · A$672m · Biotech and pharmaceuticals
- BDT & MSD Partners stake in DBG Global Enterprises Aug 2025 · A$7bn · Biotech and pharmaceuticals
- TPG acquisition of Agilex Biolabs Sep 2026 · A$160m · Biotech and pharmaceuticals
Sources
- 6 Aug 2025 MCoBeauty parent gets capital infusion from private equity investor insideretail.com.au
- 11 Aug 2025 Allens advises BDT & MSD on $1.6bn investment in DBG Health allens.com.au
- 18 Aug 2025 BDT & MSD Partners Invest AU$1.6 Billion in DBG Health globallegalchronicle.com